Share

New "Smart Probe" Immediately Alerts Potential Breast Cancer Patients to Malignant Tumors

Who: Lawrence Livermore National Laboratory

What: New Tool for Earlier and More Accurate Breast Cancer Detection

When: Wednesday, January 10, 2001 at 10 a.m.

Where: Lawrence Livermore National Laboratory, 7000 East Avenue, Building 132

NOTES:
Breast cancer is the second leading cause of death among women in the United States. In 2000, 182, 800 women were diagnosed with breast cancer and more than 40,800 women died from the disease. In response to the staggering number of breast cancer diagnoses, LLNL has partnered with San Jose-based BioLuminate, Inc. to develop the minimally invasive "Smart Probe," a new tool for earlier and more accurate breast cancer detection. The "Smart Probe" removes no tissue and is expected to achieve accuracy levels comparable to surgical biopsies in detecting cancerous cells in the breast. With the BioLuminate Smart Probe‘, women will know immediately whether a tumor is malignant or benign, eliminating the lengthy and stressful period that most patients and families go through when waiting for test results.

Reporters will be able to view a demonstration of the "Smart Probe’s" capabilities.

Press members interested in attending the press conference need to contact the LLNL Public Affairs Office at 925-422-9799 to make arrangements.

The U.S. Department of Energy’s Lawrence Livermore National Laboratory is managed by the University of California.

Laboratory news releases and photos are also available electronically on the World Wide Web of the Internet at URL http://www.llnl.gov/PAO and on UC Newswire.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.